Stocks · News reference
8-K filing — Inhibrx Biosciences, Inc. (INBX)
Filed: 2026-07-16 AccNo: 0002007919-26-000037 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Jul 16, 2026, 8:06 PM
- Checked
- Jul 16, 2026, 8:06 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Inhibrx Biosciences Q2 EPS $(2.34) Beats $(2.39) Estimate
Read original at benzinga8-K filing — Inhibrx Biosciences, Inc. (INBX)
Filed: 2026-08-13 AccNo: 0002007919-26-000044 Size: 271 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Read original at edgarInhibrx Biosciences Says FDA Accepts BLA Seeking Approval Of Ozekibart In Patients With Conventional Chondrosarcoma; PDUFA Goal Date Set For April 14, 2027
Read original at benzinga